Published: Friday, June 20, 2025 · 7:15 PM | Updated: Friday, June 20, 2025 · 7:15 PM
📊 425 views
SHARE
Morgan Stanley has adjusted its price target for Givaudan (GVDNY, Financial), increasing it from CHF 3,600 to CHF 3,650. Despite this upward revision, the investment firm maintains an Underweight rating on the shares. This adjustment reflects a cautious yet slightly more optimistic outlook on Givaudan’s future performance.
MORE IN INSIDE INVESTMENT NEWS
Moderna Outlook Surges: Bullish Q3 Beats and Upgraded 2026 Forecast Signal Alpha
Published: Friday, November 6, 2026 · 7:39 AM
Rheinmetall Plunges: Alpha Strategy Amidst Stalled Contracts
Published: Thursday, November 5, 2026 · 3:17 AM
